Loading…
Based on limited metadata, the FDA issued a Warning Letter to CBD American Shaman, LLC on November 16, 2022, regarding animal and veterinary products containing cannabidiol (CBD). While the specific violations are not detailed in the available metadata, the letter indicates regulatory concerns about how the company marketed or formulated CBD-containing animal or veterinary products. The warning falls under FDA's oversight of animal and veterinary product compliance, though the issuing office details are not available in this summary.